How mu-Opioid Receptor Recognizes Fentanyl

Area of Science:

• Structural biology
• Computational chemistry
• Pharmacology

Background:

• The opioid crisis is exacerbated by synthetic opioids like fentanyl, a potent mu-opioid receptor (mOR) agonist.
• Understanding fentanyl's precise binding mechanism to mOR is crucial for developing safer analgesics.
• Existing structural data for mOR primarily involves morphine derivatives, lacking insight into fentanyl-like compounds.

Approach:

• Utilized X-ray structure of mOR with a morphinan ligand as a starting point.
• Employed advanced simulation techniques: weighted ensemble and continuous constant pH molecular dynamics.
• Investigated the detailed binding mechanism of fentanyl with the mu-opioid receptor.

Key Points:

• Fentanyl exhibits a secondary binding mode, engaging histidine H297 in addition to the orthosteric site.
• This secondary binding is contingent on histidine H297 adopting a neutral HID tautomer state.
• Identified potential general mechanisms in G protein-coupled receptor (GPCR) ligand recognition involving alternative binding modes and tautomer states.

Conclusions:

• Elucidated the detailed binding mechanism of fentanyl with mOR, revealing a novel interaction.
• Highlights the importance of considering histidine tautomerization in protein-ligand interactions.
• Provides a foundation for designing safer analgesics and combating the synthetic opioid crisis.